224 related articles for article (PubMed ID: 27323782)
1. Prognostic significance of CD44 in human colon cancer and gastric cancer: Evidence from bioinformatic analyses.
Xia P; Xu XY
Oncotarget; 2016 Jul; 7(29):45538-45546. PubMed ID: 27323782
[TBL] [Abstract][Full Text] [Related]
2. CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach.
Cao X; Cao D; Jin M; Jia Z; Kong F; Ma H; Wang Y; Jiang J
BMC Gastroenterol; 2014 Sep; 14():157. PubMed ID: 25212506
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer.
Yang J
Med Oncol; 2020 Mar; 37(5):34. PubMed ID: 32219571
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer.
Kodama H; Murata S; Ishida M; Yamamoto H; Yamaguchi T; Kaida S; Miyake T; Takebayashi K; Kushima R; Tani M
Br J Cancer; 2017 Jan; 116(2):186-194. PubMed ID: 27931044
[TBL] [Abstract][Full Text] [Related]
5. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
6. Clinicopathologic significance of putative stem cell markers, CD44 and nestin, in gastric adenocarcinoma.
Dhingra S; Feng W; Brown RE; Zhou Z; Khoury T; Zhang R; Tan D
Int J Clin Exp Pathol; 2011; 4(8):733-41. PubMed ID: 22135720
[TBL] [Abstract][Full Text] [Related]
7. Expression of cell adhesion molecule CD44 in gastric adenocarcinoma and its prognostic importance.
Ghaffarzadehgan K; Jafarzadeh M; Raziee HR; Sima HR; Esmaili-Shandiz E; Hosseinnezhad H; Taghizadeh-Kermani A; Moaven O; Bahrani M
World J Gastroenterol; 2008 Nov; 14(41):6376-81. PubMed ID: 19009655
[TBL] [Abstract][Full Text] [Related]
8. Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients.
Stotz M; Herzog SA; Pichler M; Smolle M; Riedl J; Rossmann C; Bezan A; Stöger H; Renner W; Berghold A; Gerger A
Anticancer Res; 2017 Apr; 37(4):2011-2018. PubMed ID: 28373475
[TBL] [Abstract][Full Text] [Related]
9. Cancer Stem Cell Marker CD44 Plays Multiple Key Roles in Human Cancers: Immune Suppression/Evasion, Drug Resistance, Epithelial-Mesenchymal Transition, and Metastasis.
Dzobo K; Sinkala M
OMICS; 2021 May; 25(5):313-332. PubMed ID: 33961518
[TBL] [Abstract][Full Text] [Related]
10. CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer.
Hou W; Kong L; Hou Z; Ji H
BMC Med Genomics; 2022 Oct; 15(1):225. PubMed ID: 36316684
[TBL] [Abstract][Full Text] [Related]
11. Systemic Inflammation Response Index (SIRI), cancer stem cells and survival of localised gastric adenocarcinoma after curative resection.
Li S; Lan X; Gao H; Li Z; Chen L; Wang W; Song S; Wang Y; Li C; Zhang H; Xue Y
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2455-2468. PubMed ID: 28828692
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis.
Wang CY; Hua L; Yao KH; Chen JT; Zhang JJ; Hu JH
Int J Clin Exp Pathol; 2015; 8(1):779-85. PubMed ID: 25755774
[TBL] [Abstract][Full Text] [Related]
14. Expression of Cancer Stem Cell Marker CD44 and Its Polymorphisms in Patients with Chronic Gastritis, Precancerous Gastric Lesion, and Gastric Cancer: A Cross-Sectional Multicenter Study in Thailand.
Tongtawee T; Wattanawongdon W; Simawaranon T; Kaewpitoon S; Kaengpenkae S; Jintabanditwong N; Tangjanyatham P; Ratchapol W; Kangwantas K; Dechsukhum C; Leeanansaksiri W; Kaewpitoon N; Matrakool L; Panpimanmas S
Biomed Res Int; 2017; 2017():4384823. PubMed ID: 29445738
[TBL] [Abstract][Full Text] [Related]
15. A CD44-specific peptide, RP-1, exhibits capacities of assisting diagnosis and predicting prognosis of gastric cancer.
Li W; Jia H; Wang J; Guan H; Li Y; Zhang D; Tang Y; Wang TD; Lu S
Oncotarget; 2017 May; 8(18):30063-30076. PubMed ID: 28415792
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Cyclin D1 and CD44 Expression in Gastric Adenocarcinoma.
Ibrahim HM; AbdElbary AM; Mohamed SY; Elwan A; Abdelhamid MI; Ibrahim A
J Gastrointest Cancer; 2019 Sep; 50(3):370-379. PubMed ID: 29497929
[TBL] [Abstract][Full Text] [Related]
17. Ratio of CD44 epithelial variant to CD44 hematopoietic variant is a useful prognostic indicator in gastric and colorectal carcinoma.
Shibuya Y; Okabayashi T; Oda K; Tanaka N
Jpn J Clin Oncol; 1998 Oct; 28(10):609-14. PubMed ID: 9839501
[TBL] [Abstract][Full Text] [Related]
18. A reciprocal regulatory circuit between CD44 and FGFR2 via c-myc controls gastric cancer cell growth.
Park J; Kim SY; Kim HJ; Kim KM; Choi EY; Kang MS
Oncotarget; 2016 May; 7(19):28670-83. PubMed ID: 27107424
[TBL] [Abstract][Full Text] [Related]
19. Significance of NQO1 overexpression for prognostic evaluation of gastric adenocarcinoma.
Lin L; Qin Y; Jin T; Liu S; Zhang S; Shen X; Lin Z
Exp Mol Pathol; 2014 Apr; 96(2):200-5. PubMed ID: 24384455
[TBL] [Abstract][Full Text] [Related]
20. Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer.
Ryu HS; Park DJ; Kim HH; Kim WH; Lee HS
Hum Pathol; 2012 Apr; 43(4):520-8. PubMed ID: 22018628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
